A detailed history of Thompson Siegel & Walmsley LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 306,793 shares of BIO stock, worth $104 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
306,793
Previous 390,020 21.34%
Holding current value
$104 Million
Previous $107 Million 3.63%
% of portfolio
1.53%
Previous 1.71%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$263.97 - $344.64 $22 Million - $28.7 Million
-83,227 Reduced 21.34%
306,793 $103 Million
Q2 2024

Aug 08, 2024

BUY
$268.26 - $339.48 $10.7 Million - $13.6 Million
40,006 Added 11.43%
390,020 $107 Million
Q1 2024

May 09, 2024

BUY
$304.11 - $351.99 $468,633 - $542,416
1,541 Added 0.44%
350,014 $121 Million
Q4 2023

Feb 07, 2024

BUY
$269.37 - $365.04 $9.67 Million - $13.1 Million
35,890 Added 11.48%
348,473 $113 Million
Q3 2023

Nov 08, 2023

BUY
$350.25 - $422.63 $6.45 Million - $7.78 Million
18,419 Added 6.26%
312,583 $112 Million
Q2 2023

Aug 10, 2023

BUY
$359.49 - $486.4 $32.7 Million - $44.3 Million
91,013 Added 44.8%
294,164 $112 Million
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $807,653 - $970,287
1,929 Added 0.96%
203,151 $97.3 Million
Q4 2022

Feb 10, 2023

BUY
$351.71 - $456.01 $70.8 Million - $91.8 Million
201,222 New
201,222 $84.6 Million
Q3 2022

Oct 25, 2022

BUY
$412.59 - $563.26 $7.83 Million - $10.7 Million
18,974 New
18,974 $7.92 Million
Q4 2018

Feb 11, 2019

SELL
$220.1 - $309.0 $3,741 - $5,253
-17 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$289.28 - $326.15 $4,917 - $5,544
-17 Reduced 50.0%
17 $5,000
Q1 2018

May 08, 2018

SELL
$233.97 - $274.11 $225,313 - $263,967
-963 Reduced 96.59%
34 $9,000
Q3 2017

Nov 08, 2017

SELL
$212.27 - $242.28 $398,006 - $454,275
-1,875 Reduced 65.29%
997 $222,000
Q2 2017

Aug 09, 2017

BUY
N/A
2,872
2,872 $650,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.35B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.